Lataa...
Recent advances in triple negative breast cancer: the immunotherapy era
BACKGROUND: Several accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. The phase III IMpassion130 trial comparing chemotherapy plus atezolizumab versus chemotherapy plus placebo brought breast cancer into the immunotherapy era. Nevertheless, despi...
Tallennettuna:
| Julkaisussa: | BMC Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6507064/ https://ncbi.nlm.nih.gov/pubmed/31068190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1326-5 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|